Key information

🔎 Fund Overview

Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The Company has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine is comprised of chemistry, including chemical compounds, polymers, and enzymes. Its product pipeline comprises two products, which include the G4 Sequencing Platform (G4) and the PX system (the PX). The G4 platform is a benchtop genomic sequencer designed to produce fast and accurate results. The G4 is designed to target the NGS market for particular applications. The PX is its second product in development and is a multiomics platform designed to target the markets for single-cell, spatial analysis and proteomics. Its PX platform leverages its sequencing technology, applying it as an in-situ readout to look at ribonucleic acid (RNA) and proteins in single cells and tissues.